CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-16 | Anicetti Vincent R Chief Operating Officer | Option exercise | +2,500 | $2.50 | $6K | 21,810 |
| 2019-09-16 | Anicetti Vincent R Chief Operating Officer | Sale | −2,500 | $20.03 | $50K | 19,310 |
| 2019-09-16 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −2,500 | 42,488 | ||
| 2019-08-21 | Viret Jean-Frederic Chief Financial Officer | Option exercise | +6,318 | $10.05 | $63K | 14,831 |
| 2019-08-21 | Viret Jean-Frederic Chief Financial Officer | Sale | −260 | $20.73 | $5K | 14,571 |
| 2019-08-21 | Viret Jean-Frederic Chief Financial Officer | Sale | −6,058 | $21.75 | $132K | 8,513 |
| 2019-08-21 | Viret Jean-Frederic Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −6,318 | 120,523 | ||
| 2019-08-19 | Viret Jean-Frederic Chief Financial Officer | Sale | −3,000 | $19.04 | $57K | 8,513 |
| 2019-08-14 | Anicetti Vincent R Chief Operating Officer | Option exercise | +2,500 | $2.50 | $6K | 21,810 |
| 2019-08-14 | Anicetti Vincent R Chief Operating Officer | Sale | −2,500 | $19.00 | $48K | 19,310 |
| 2019-08-14 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −2,500 | 44,988 | ||
| 2019-07-15 | Anicetti Vincent R Chief Operating Officer | Option exercise | +2,500 | $2.50 | $6K | 21,810 |
| 2019-07-15 | Anicetti Vincent R Chief Operating Officer | Sale | −2,500 | $19.20 | $48K | 19,310 |
| 2019-07-15 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −2,500 | 47,488 | ||
| 2019-07-02 | HEALY JAMES Director | Sale | −160,000 | $22.61 | $3.6M | 1,933,221 |
| 2019-06-28 | HEALY JAMES Director | Sale | −200,000 | $22.05 | $4.4M | 2,093,221 |
| 2019-06-20 | HEALY JAMES Director | Sale | −317,130 | $21.37 | $6.8M | 2,293,221 |
| 2019-06-19 | Viret Jean-Frederic Chief Financial Officer | Sale | −667 | $20.00 | $13K | 11,513 |
| 2019-06-19 | Viret Jean-Frederic Chief Financial Officer | Option exercise | +3,159 | $10.05 | $32K | 14,672 |
| 2019-06-19 | Viret Jean-Frederic Chief Financial Officer | Sale | −3,059 | $20.32 | $62K | 11,613 |
Page 20 of 39 · 768 trades